Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
biomodal logo — Reveal the power of the 6-base genome and discover biology i...

biomodal

Reveal the power of the 6-base genome and discover biology in every mode

Founded 2012 United Kingdom Cambridge, United Kingdom 99 employees Series Unknown Biotechnology, Health Care +1

General Information

Company Name biomodal
Founded Year 2012
Location United Kingdom Cambridge, United Kingdom +2
Employees 99
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Series Unknown
Social

Get notified when biomodal moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About biomodal

biomodal, founded in 2012, is a pioneering company at the forefront of biotech innovation. Specializing in omics-based life sciences technology and analytics, biomodal is known for its duet multiomics solutions that enhance epigenetic data acquisition from minimal DNA samples. This approach allows for unparalleled insight into complex biological systems with applications spanning cancer, neurodegenerative diseases, and ageing.

The company, headquartered in the United Kingdom, has gained significant industry recognition, notably being listed in "The Sunday Times 100 Tech 2026." Biomodal's innovative sequencing technologies unlock the synergies between genetic and epigenetic data, offering groundbreaking potential for advancements in biotechnology and health care.

Despite its last documented investment being a Venture Round in January 2015, led by Sequoia Capital Global Equities, biomodal continues to attract attention for its capacity to advance life sciences through its transformative products and technologies.

Taxonomy: 6-base genome, multiomics solutions, epigenetics, single-base-resolution sequencing, cancer research, neurodegenerative disease, ageing research, genetic information analysis, epigenetic information, biomarker discovery, diagnostic assays, precision medicine, low input DNA analysis, genetic and epigenetic combinatorial insights, life sciences technology

Services & Products

duet multiomics solution evoC
duet multiomics solution +modC
custom multiomic solutions
modality XPLR for explorative research
integrated genetic and epigenetic sequencing

Target Customers

research institutions biotech companies healthcare providers clinical researchers pharmaceutical companies

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1 •••• •••• 01 Jan 2015

biomodal Alternatives & Competitors

biomodal vs
BIOMOLE SRL
BIOMOLE SRL Italy

An Academic spin-off contextualised in the transfer technology-III Mission of the University of Turi...

2 employees
Biotechnology, Health Care
biomodal vs
MyDNAge (Epimorphy LLC)
MyDNAge (Epimorphy LLC) United States

The gold standard of biological age tests. Revolutionizing the path to healthy aging.

3 employees
Health Care
Compare biomodal vs MyDNAge (Epimorphy LLC)
biomodal vs
Clock Foundation
Clock Foundation

Advancing the science of epigenetic aging clocks to predict healthspan and lifespan, while making te...

3 employees
Biopharma, Biotechnology
Also compare with: biomodal vs Matter Bio Matter Bio biomodal vs Finanvo.in Finanvo.in

FAQ About biomodal

Reveal the power of the 6-base genome and discover biology in every mode
biomodal was founded in 2012.
biomodal is headquartered in Cambridge, United Kingdom.
biomodal operates in the following industries: Biotechnology, Health Care, Life Sciences.
biomodal has approximately 99 employees.
biomodal has completed 1 funding round. The latest funding stage is Series Unknown.
biomodal offers: duet multiomics solution evoC, duet multiomics solution +modC, custom multiomic solutions, modality XPLR for explorative research, integrated genetic and epigenetic sequencing.
Top alternatives and competitors to biomodal include BIOMOLE SRL, MyDNAge (Epimorphy LLC), Clock Foundation, Matter Bio, Finanvo.in. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
biomodal and BIOMOLE SRL are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors biomodal and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy